Tag: Novo
Trump drug price deal: Burning questions after Lilly, Novo agreement
The recent deal struck by the Trump administration to increase access to and decrease the cost of weight…
TrumpRx to offer discount weight loss drugs after Lilly, Novo deals
The Trump administration made a significant announcement on Thursday regarding a deal with Novo Nordisk and Eli Lilly…
Novo Nordisk trims outlook as obesity drug maker loses ground to Eli Lilly
Novo Nordisk, a leading pharmaceutical company known for its Wegovy obesity drug, has recently faced challenges in the…
Novo Nordisk and Pfizer’s bidding war for Metsera escalates despite legal threats
Novo Nordisk and Pfizer are currently engaged in a fierce bidding war over the acquisition of obesity biotech…
Eli Lilly, Novo Nordisk near deal with Trump on weight loss drug prices
The Trump administration is reportedly in the final stages of negotiations with pharmaceutical giants Eli Lilly and Novo…
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
Pfizer Files Lawsuit Against Metsera and Novo Nordisk Over Merger Agreement In a recent development, Pfizer has taken…
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
Metsera Emerges as the Hottest Contender in the Obesity Drug Market Metsera, a New York-based biotech company, has…
Akero Therapeutics (AKRO) Jumps 16% on $5.2-Billion Novo Nordisk Merger
We have recently featured a piece titled 10 Major Players With Significant Gains; 6 Reach All-Time Highs. Among…
Why Shares in Novo Nordisk Bumped Higher Today
Novo Nordisk is significantly enhancing its footprint in the U.S. manufacturing industry with plans for facility expansion. The…
Cash pay is ‘going to constitute a major part of the Wegovy business’: Novo Nordisk CFO
Novo Nordisk (NVO) faced a setback with an earnings miss, causing a 4% drop in its stock price.…
Novo Nordisk reports second quarter earnings missing Wall Street estimates on slower GLP-1 sales
Novo Nordisk (NVO) stock took a hit in pre-market trading after the company reported a miss on both…
Novo Nordisk shares plummet as 2025 guidance is cut, overshadowing new CEO
Novo Nordisk, a major player in the pharmaceutical industry, has recently faced setbacks that have led to a…